Journal of Liver Cancer

CrossRef Text and Data Mining

Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.

Advances in immune checkpoint inhibitors for hepatocellular carcinoma

Ji Won Han, Su-Hyung Park

J Liver Cancer. 2021;21(2):139-145. Published online September 30, 2021
DOI: https://doi.org/10.17998/jlc.2021.09.24

Immune checkpoint inhibitors for hepatocellular carcinoma

Venkata Prasuja Nakka

Theranostics and Precision Medicine for the Management of Hepatocellular Carcinoma, Volume 3. 2022;215-223

Link1 Link2

Immune Checkpoint Inhibitors for the Treatment of Hepatocellular Carcinoma

Mercedes Iñarrairaegui, Delia D’Avola, Bruno Sangro

Immunotherapy of Hepatocellular Carcinoma. 2017;51-68

Link1

Transarterial Chemoembolization Combined with Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors versus Immune Checkpoint Inhibitors Plus Tyrosine Kinase Inhibitors for Advanced Hepatocellular Carcinoma

Jin-Tao Huang, Bin-Yan Zhong, Nan Jiang, Wan-Ci Li, Shuai Zhang, Yu Yin, Jun Yang, Jian Shen, Wan-Sheng Wang, Xiao-Li Zhu

Journal of Hepatocellular Carcinoma. 2022;Volume 9:1217-1228

Link1 Link2

Advances in Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma

Yue Chen, Haoyue Hu, Xianglei Yuan, Xue Fan, Chengda Zhang

Frontiers in Immunology. 2022;13:

Link1

Immunotherapy and Hepatocellular Carcinoma

Jacob Zaemes, Muneeb Rehman, Coleman Smith, Ruth He

Immune Checkpoint Inhibitors - New Insights and Recent Progress [Working Title]. 2022;

Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: Opportunities and Challenges

Xiufeng Liu, Shukui Qin

The Oncologist. 2019;24(S1):S3-S10

Link1 Link2 Link3

Link4

Immune Phenotype and Immune Checkpoint Inhibitors for the Treatment of Human Hepatocellular Carcinoma

Naoshi Nishida, Masatoshi Kudo

Cancers. 2020;12(5):1274

Link1

Immune Checkpoint Inhibitors in Hepatocellular Carcinoma: An Overview

Diederick J. van Doorn, Robert Bart Takkenberg, Heinz-Josef Klümpen

Pharmaceuticals. 2020;14(1):3

Link1

Immune Checkpoint Inhibitors for Advanced Hepatocellular Carcinoma: Monotherapies and Combined Therapies

Tao Ouyang, Xuefeng Kan, Chuansheng Zheng

Frontiers in Oncology. 2022;12:

Link1

Genetic Heterogeneity, Therapeutic Hurdle Confronting Sorafenib and Immune Checkpoint Inhibitors in Hepatocellular Carcinoma

Sara Atwa, Margarete Odenthal, Hend El Tayebi

Cancers. 2021;13(17):4343

Link1